{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:28Z","timestamp":1791294028481,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bpobgyn.2025.102688","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:07:46Z","timestamp":1764086866000},"page":"102688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Borderline ovarian tumours: A comprehensive review of published evidence"],"prefix":"10.1016","volume":"104","author":[{"given":"Kyriaki-Barbara","family":"Papalois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel George","family":"Oxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Jeyarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Brockbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Phadnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s13193-017-0697-3","article-title":"Management of borderline ovarian tumors-still a gray zone","volume":"8","author":"Nayyar","year":"2017","journal-title":"Indian J Surg Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102688_bib2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.23724","article-title":"Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer","volume":"123","author":"Sk\u00edrnisd\u00f3ttir","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib3","series-title":"Geburtshilfe und Frauenheilkunde","first-page":"807","article-title":"Borderline tumors of the ovary-a systematic review","author":"Du","year":"2009"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102688_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","article-title":"Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study","volume":"83","author":"Riman","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib6","unstructured":"Taylor HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet1929. p. pp.204-230. ."},{"issue":"3 Pt 2","key":"10.1016\/j.bpobgyn.2025.102688_bib7","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1006\/gyno.1994.1342","article-title":"Management of epithelial ovarian tumors of low malignant potential","volume":"55","author":"Trimble","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib8","first-page":"686","article-title":"Ovarian tumors. A review","volume":"87","author":"Scully","year":"1977","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/gyno.1996.4592","article-title":"Unusual features of serous neoplasms of low malignant potential during pregnancy","volume":"65","author":"Mooney","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.bpobgyn.2025.102688_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"143","author":"Berek","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","article-title":"Management of borderline ovarian tumours","volume":"41","author":"Gershenson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","article-title":"Borderline ovarian tumours","volume":"26","author":"Trop\u00e9","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","article-title":"KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants","volume":"103","author":"Mayr","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102688_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030545","article-title":"Molecular biomarkers in borderline ovarian tumors: towards personalized treatment and prognostic assessment","volume":"17","author":"Drymiotou","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib16","first-page":"7","article-title":"Molecular pathogenesis of borderline and invasive ovarian tumors","volume":"14","author":"Stanojevic","year":"2009","journal-title":"J buon"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/modpathol.2017.121","article-title":"KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome","volume":"31","author":"Zuo","year":"2018","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2025.102688_bib18","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/annonc\/mdw090","article-title":"Management of borderline ovarian tumors","volume":"27","author":"du Bois","year":"2016","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3802\/jgo.2015.26.4.343","article-title":"Controversies in borderline ovarian tumors","volume":"26","author":"Seong","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib20","first-page":"403","article-title":"Management of borderline ovarian tumours: a comprehensive review of the literature","volume":"8","author":"Abascal-Saiz","year":"2014","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2025.03.052","article-title":"Hysterectomy or not for borderline ovarian tumor in menopause?","volume":"196","author":"Raimondo","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102688_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1586\/era.10.90","article-title":"Clinical management of borderline ovarian tumors","volume":"10","author":"Trillsch","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejogrb.2017.04.016","article-title":"British gynaecological cancer society (BGCS) epithelial ovarian\/fallopian tube\/primary peritoneal cancer guidelines: recommendations for practice","volume":"213","author":"Fotopoulou","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib24","unstructured":"N C. ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. In: Colombo N, Sessa C, Bois Ad, Ledermann J, McCluggage WG, McNeish I, et al., editors. Annals of Oncology2019.."},{"key":"10.1016\/j.bpobgyn.2025.102688_bib25","author":"Oncology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1283-081X(10)70778-5","article-title":"Cirug\u00eda de los tumores epiteliales malignos del ovario","volume":"46","author":"Morice","year":"2010","journal-title":"EMC - Ginecolog\u00eda-Obstetricia"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2017.01.019","article-title":"Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors","volume":"144","author":"Matsuo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2147\/CMAR.S287509","article-title":"Predicting lymph node involvement in borderline ovarian tumors with a quantitative model and nomogram: a retrospective cohort study","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/humrep\/del381","article-title":"Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study","volume":"22","author":"Palomba","year":"2007","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ygyno.2005.03.010","article-title":"Fertility and recurrence results of conservative surgery for borderline ovarian tumors","volume":"97","author":"Boran","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2014.06.002","article-title":"A nationwide study of serous \"borderline\" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population","volume":"134","author":"Hannibal","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ygyno.2016.11.007","article-title":"A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma","volume":"144","author":"Hannibal","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102688_bib33","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the arbeitsgmeinschaft gyn\u00e4kologische onkologie (AGO) study group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib34","doi-asserted-by":"crossref","unstructured":"\u2217 du Bois A, Reuss A Fau - Pujade-Lauraine E, Pujade-Lauraine E Fau - Harter P, Harter P Fau - Ray-Coquard I, Ray-Coquard I Fau - Pfisterer J, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). 2009(0008-543X (Print)).https:\/\/doi.org\/10.1002\/cncr.24149.https:\/\/pubmed.ncbi.nlm.nih.gov\/19189349\/..","DOI":"10.1002\/cncr.24149"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2011.03.021","article-title":"Accuracy of frozen section diagnosis of borderline ovarian tumors","volume":"122","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2007.06.008","article-title":"Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature","volume":"107","author":"Tempfer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2019.01.021","article-title":"Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery","volume":"111","author":"Delle Marchette","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib38","first-page":"1872","author":"Moss","year":"2024"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib39","series-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) national comprehensive cancer network","first-page":"23","author":"Network","year":"2023"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib40","first-page":"1460","article-title":"Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours","author":"Song","year":"2011","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1245\/s10434-010-1293-8","article-title":"Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)","volume":"18","author":"Koskas","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102688_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3332\/ecancer.2020.1031","article-title":"Borderline ovarian tumours: management in the era of fertility-sparing surgery","volume":"14","author":"Maramai","year":"2020","journal-title":"ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0015-0282(00)01633-2","article-title":"Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors","volume":"75","author":"Morice","year":"2001","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jmig.2014.12.009","article-title":"Postoperative adhesions as a consequence of pelvic surgery","volume":"22","author":"Bolnick","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib47","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10815-020-01738-1","article-title":"Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin","volume":"37","author":"Buonomo","year":"2020","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib48","first-page":"417","article-title":"The role of wedge resection of the ovary as a cause for mechanical sterility","volume":"141","author":"Weinstein","year":"1975","journal-title":"Surg Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Dara\u00ef","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2004.02.114","article-title":"Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report","volume":"82","author":"Fasouliotis","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib51","unstructured":"Li S, Lin H, Xie Y, Jiao X, Qiu Q, Zhang Q. Live births after in vitro fertilization with fertility-sparing surgery for borderline ovarian tumors: a case series and literature review.Gynecol Obstetr Investigat (1423-002X (Electronic)).https:\/\/doi.org\/10.1159\/000497203.https:\/\/pubmed.ncbi.nlm.nih.gov\/30799426\/.."},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1757-2215-6-48","article-title":"Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)","volume":"6","author":"Trillsch","year":"2013","journal-title":"J Ovarian Res"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2025.102688_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/annonc\/mdi083","article-title":"Laparoscopic management of borderline ovarian tumors: results of a French multicenter study","volume":"16","author":"Fauvet","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib55","unstructured":"Morice P, Camatte S Fau - Larregain-Fournier D, Larregain-Fournier D Fau - Thoury A, Thoury A Fau - Duvillard P, Duvillard P Fau - Castaigne D, Castaigne D. Port-site implantation after laparoscopic treatment of borderline ovarian tumors.Obstetr Gynecol (0029-7844 (Print)).."},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102688_bib56","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/00016340701286934","article-title":"Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy","volume":"86","author":"\u00d8degaard","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102688_bib57","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.fertnstert.2010.04.045","article-title":"Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary","volume":"94","author":"Kane","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib58","unstructured":"Trop\u00e9 CG, Kristensen G Fau - Makar A, Makar A. Surgery for borderline tumor of the ovary. (8756-0437).https:\/\/doi.org\/10.1002\/1098-2388(200007\/08)19:1<69::aid-ssu11>3.0.co;2-e.."},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib59","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.21873\/invivo.12517","article-title":"Areas to improve quality of life after ovarian tumor surgery and adjuvant treatment","volume":"35","author":"Dobilas","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7819-11-13","article-title":"Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor","volume":"11","author":"Romeo","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"13","key":"10.1016\/j.bpobgyn.2025.102688_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133645","article-title":"Risk factors for recurrence of borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the francogyn Group","volume":"11","author":"Ozenne","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101377","article-title":"Identification of clinical and molecular features of recurrent serous borderline ovarian tumour","volume":"46","author":"Lu","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib63","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1470-2045(18)30837-4","article-title":"Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study","volume":"20","author":"Froyman","year":"2019","journal-title":"Lancet Oncol"},{"issue":"S1","key":"10.1016\/j.bpobgyn.2025.102688_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/uog.7771","article-title":"OC01.03: ultrasound in diagnosis of new and recurrent borderline ovarian tumors","volume":"36","author":"Fischerova","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/uog.12270","article-title":"Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"40","author":"Sharma","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102688_bib66","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/gyno.2000.5811","article-title":"Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors","volume":"78","author":"Engelen","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/annonc\/mdp267","article-title":"Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary","volume":"21","author":"Uzan","year":"2010","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102688_bib69","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102688_bib70","first-page":"6725","article-title":"Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors","volume":"34","author":"Lazarou","year":"2014","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2005.09.021","article-title":"Conservative surgery for borderline ovarian tumors: a review","volume":"100","author":"Tinelli","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102688_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/gyno.1993.1279","article-title":"Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors","volume":"51","author":"Trop\u00e9","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102688_bib73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib74","first-page":"93","article-title":"Stage I borderline ovarian tumors","volume":"59","author":"Creasman","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0090-8258(91)90314-U","article-title":"Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a gynecologic oncology group study)","volume":"41","author":"Sutton","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib76","first-page":"2053","article-title":"British gynaecological cancer society and British menopause society guidelines: management of menopausal symptoms following treatment of gynaecological cancer","author":"Taylor","year":"2024","journal-title":"Post Reprod Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102688_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101966","article-title":"Borderline ovarian tumors: french guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation","volume":"50","author":"Bourdel","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"42","key":"10.1016\/j.bpobgyn.2025.102688_bib78","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1038\/onc.2011.539","article-title":"A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer","volume":"31","author":"Ratner","year":"2012","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib79","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","article-title":"Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis","volume":"198","author":"Kurman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib80","series-title":"Understanding the health care needs of people with multiple health conditions","author":"M","year":"2018"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102688_bib81","first-page":"360","article-title":"Hoping for the best, preparing for the worst: the lived experiences of women undergoing ovarian cancer surgery","volume":"21","author":"Seibaek","year":"2012","journal-title":"Eur J Cancer Care"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102688_bib82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ijgc-2019-001176","article-title":"British gynaecological cancer society recommendations and guidance on patient-initiated follow-up (PIFU)","volume":"30","author":"Newton","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2025.102688_bib83","series-title":"Role of laparoscopic surgery in borderline ovarian tumor: an overview","author":"P","year":"2017"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102688_bib84","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00404-011-2194-1","article-title":"The preoperative diagnosis of borderline ovarian tumors: a review of current literature","volume":"285","author":"Morotti","year":"2012","journal-title":"Arch Gynecol Obstet"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:01:01Z","timestamp":1769860861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":84,"alternative-id":["S1521693425001129"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102688","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Borderline ovarian tumours: A comprehensive review of published evidence","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102688"}}